Please login to the form below

Not currently logged in
Email:
Password:

Bio Products Laboratory

This page shows the latest Bio Products Laboratory news and features for those working in and with pharma, biotech and healthcare.

CHMP backs orphan drugs Uptravi and Coagadex

CHMP backs orphan drugs Uptravi and Coagadex

CHMP backs orphan drugs Uptravi and Coagadex. EMA advisors set Actelion and Bio Products therapies on path to European approval. ... The panel backed Coagudex (factor X concentrate) from Bio Products Laboratory for the treatment of factor X deficiency, a

Latest news

  • BPL bags FDA approval for rare bleeding disorder therapy BPL bags FDA approval for rare bleeding disorder therapy

    UK firm Bio Products Laboratory (BPL) has won US approval for Coagadex, the first drug approved specifically for patients with the rare bleeding disorder hereditary Factor X deficiency.

  • PMEA 2005: Winners in pictures

    Innovation Award. Winners: Dermatology by Medlock Medical (submitted by The Foundry Communications) &Subgam - The Butterfly Club by Bio Products Laboratory.

  • Communiqué Awards 2005: Results

    Agency: Athena Medical PR. Client: Bio Products Laboratory. Campaign: Subgam - The Butterfly Club. ... Client: Bio Products Laboratory. Campaign: The Launch of Subgam. Agency: Virgo Health PR.

  • Communiqué Awards 2007: Results

    Finalist:. Agency:Oyster Healthcare Communications. Client:Bio Products Laboratory. Campaign:Immunotherapeutics Quarterly (IQ) magazine. ... 4) Best Product Campaign. Sponsored by Edelman. WINNER:. Agency:Cohn &Wolfe. Client:Roche Products.

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics